Authorities said the exec provided inside information in 2015 about a pending $3.2 billion buyout offer from Israel-based generic drug giant Teva Pharmaceutical Industries Limited to his friends and family so they could trade securities.
Ex-pharmaceutical company boss faces insider trading charges
